Jeffrey Castelli

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President - Program and Portfolio Management Amicus Therapeutics, Inc. Feb. 1, 2013 - Jan. 1, 2015
Jeffrey Castelli's trades of Amicus Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
13.10
Quantity 1,654 -0.5%
Value US$21,667
Transaction date
Sale
Price
13.25
Quantity 17,500 -4.6%
Value US$231,875
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2025-11-24
S Sale
84,120 -31.7%
334.69
US$3,624,669 		84,120 -31.7% 334.69 US$3,624,669
2025-11-24 2025-11-24
PrS Proposed sale
40,464
305.80
US$2,471,070 		40,464 305.80 US$2,471,070
2023-12-29 2023-12-28
S Sale
71,088 +1.8%
179.45
US$4,884,700 		71,088 +1.8% 179.45 US$4,884,700
2023-12-28 2023-12-28
PrS Proposed sale
1,575
14.43
US$22,727 		1,575 14.43 US$22,727
2023-12-20 2023-12-20
PrS Proposed sale
17,500
13.18
US$230,650 		17,500 13.18 US$230,650
2023-12-20 2023-12-20
S Sale
1,654 -0.5%
13.10
US$21,667 		1,654 -0.5% 13.10 US$21,667
2023-12-20 2023-12-19
S Sale
17,500 -4.6%
13.25
US$231,875 		17,500 -4.6% 13.25 US$231,875
2023-12-19 2023-12-19
PrS Proposed sale
17,500
12.66
US$221,550 		17,500 12.66 US$221,550